Leadership & Pay ·
On June 9, 2026, Ascendis Pharma A/S's board of directors granted 27,030 warrants to specific employees
ASNDAscendis Pharma A/S
On June 9, 2026, Ascendis Pharma A/S's board of directors granted 27,030 warrants to specific employees. Each warrant allows for the subscription of one ordinary share at an exercise price of $213.23 per share. The warrants follow a vesting schedule where 25% vest on the one-year anniversary of the grant, with the remaining 75% vesting monthly over 36 months thereafter, subject to continued service and certain exit events. Following this issuance, 1,553,563 warrants remain available for future grants. The company amended its Articles of Association to facilitate this grant. Ascendis Pharma A/S is a biotechnology company focused on developing proprietary technologies for hormone therapies.